CoChat

Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer’s Disease

Open access
Teunissen, Charlotte E., Chiu, Ming-Jang, Yang, Che-Chuan, Yang, Shieh-Yueh, Scheltens, Philip, Zetterberg, Henrik, Blennow, Kaj · 2018 · Journal of Alzheimer’s Disease
Cited by 144

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The 42 amino acid form of amyloid-β (Aβ 42) plays a key role in the pathogenesis of Alzheimer’s disease (AD) and is a core biomarker for the diagnosis of AD. Numerous studies have shown that cerebrospinal fluid (CSF) Aβ 42 concentrations are decreased in AD, when measured by enzyme-linked immunosorbent assay (ELISA) and other conventional immunoassays. While most studies report no change in plasma Aβ 42, independent studies using the immunomagnetic reduction (IMR) technique report an increase in plasma Aβ 42 levels in AD. To confirm the opposite changes of Aβ 42 levels in CSF and plasma for AD, we assayed the levels of Aβ 42 in plasma of subjects with known CSF Aβ 42 levels. In total 43 controls and 63 AD patients were selected at two sites: the VU University Medical Center ( n = 55) and Sahlgrenska University Hospital ( n = 51). IMR and ELISA were applied to assay Aβ 42 in plasma and CSF, respectively. We found a moderately negative correlation between plasma and CSF Aβ 42 levels in AD patients ( r = –0.352), and a weakly positive correlation in controls ( r = 0.186). These findings further corroborate that there are opposite changes of Aβ 42 levels in CSF and plasma in AD. The possible causes for the negative correlation are discussed by taken assay technologies, Aβ 42 transport from brain to peripheral blood, and sample matrix into account.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-170784

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 144

Metadata

Authors
Teunissen, C. E., Chiu, M.-J., Yang, C.-C., Yang, S.-Y., Scheltens, P., Zetterberg, H., & Blennow, K.
Venue
Journal of Alzheimer’s Disease
Published
2018-03-24
Volume
62
Issue
4
Pages
1857-1863
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W2794628157
Cited by
144
References
16
FWCI
8.91
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.